Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139.

Jouravleva EA, McDonald GA, Marsh JW, Taylor RK, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1998 Jun;66(6):2535-9.

2.

Characterization and possible functions of a new filamentous bacteriophage from Vibrio cholerae O139.

Jouravleva EA, McDonald GA, Garon CF, Boesman-Finkelstein M, Finkelstein RA.

Microbiology. 1998 Feb;144 ( Pt 2):315-24.

PMID:
9493369
3.

Adherence of Vibrio cholerae to cultured differentiated human intestinal cells: an in vitro colonization model.

Bénitez JA, Spelbrink RG, Silva A, Phillips TE, Stanley CM, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1997 Aug;65(8):3474-7.

4.

Colonial opacity variations among the choleragenic vibrios.

Finkelstein RA, Boesman-Finkelstein M, Sengupta DK, Page WJ, Stanley CM, Phillips TE.

Microbiology. 1997 Jan;143 ( Pt 1):23-34.

PMID:
9025275
5.

Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A.

Robert A, Silva A, Benitez JA, Rodriguez BL, Fando R, Campos J, Sengupta DK, Boesman-Finkelstein M, Finkelstein RA.

Vaccine. 1996 Nov;14(16):1517-22.

PMID:
9014293
6.

A nontoxic chimeric cholera toxin analog.

Boesman-Finkelstein M, Peterson JW, Thai LS, Finkelstein RA.

Ann N Y Acad Sci. 1996 Oct 25;797:266-8. No abstract available.

PMID:
8993375
7.

A nontoxic cholera enterotoxin (CT) analog is chimeric with regard to both epitypes of CT-B subunits, CT-B-1 and CT-B-2.

Boesman-Finkelstein M, Peterson JW, Thai LS, Finkelstein RA.

Infect Immun. 1996 Jan;64(1):346-8.

8.

Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge.

Sengupta DK, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1996 Jan;64(1):343-5.

9.

Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Häse CC, Thai LS, Boesman-Finkelstein M, Mar VL, Burnette WN, Kaslow HR, Stevens LA, Moss J, Finkelstein RA.

Infect Immun. 1994 Aug;62(8):3051-7.

10.

Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment.

Finkelstein RA, Boesman-Finkelstein M, Chang Y, Häse CC.

Infect Immun. 1992 Feb;60(2):472-8.

11.

Heterogeneity of immunotypes of heat-labile enterotoxins of enterotoxigenic Escherichia coli of human origin.

Qu ZH, Boesman-Finkelstein M, Kazemi M, Finkelstein RA.

J Infect Dis. 1991 Oct;164(4):796-9.

PMID:
1894939
12.

Urea-induced release of heat-labile enterotoxin from Escherichia coli.

Qu ZH, Boesman-Finkelstein M, Finkelstein RA.

J Clin Microbiol. 1991 Apr;29(4):773-7.

13.

Bovine lactogenic immunity against pediatric enteropathogens.

Boesman-Finkelstein M, Finkelstein RA.

Adv Exp Med Biol. 1991;310:361-7. Review. No abstract available.

PMID:
1809011
14.

Molecular cloning and nucleotide sequence analysis of cholera toxin genes of the CtxA- Vibrio cholerae strain Texas Star-SR.

Brickman TJ, Boesman-Finkelstein M, Finkelstein RA, McIntosh MA.

Infect Immun. 1990 Dec;58(12):4142-4.

15.

Passive oral immunisation of children.

Boesman-Finkelstein M, Finkelstein RA.

Lancet. 1989 Dec 2;2(8675):1336. No abstract available.

PMID:
2574282
16.

Inhibition of enteropathogenic bacteria by human milk whey in vitro.

Dolan SA, Boesman-Finkelstein M, Finkelstein RA.

Pediatr Infect Dis J. 1989 Jul;8(7):430-6.

PMID:
2787902
17.

Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes.

Boesman-Finkelstein M, Walton NE, Finkelstein RA.

Infect Immun. 1989 Apr;57(4):1227-34.

18.

Comparative study of Vibrio cholerae non-O1 protease and soluble hemagglutinin with those of Vibrio cholerae O1.

Honda T, Booth BA, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1987 Feb;55(2):451-4.

19.

Antimicrobial activity of human milk against pediatric pathogens.

Dolan SA, Boesman-Finkelstein M, Finkelstein RA.

J Infect Dis. 1986 Oct;154(4):722-5. No abstract available.

PMID:
3091710
20.

Competitive enzyme-linked immunosorbent assay for cholera-related enterotoxins in Salmonella typhimurium.

Hariharan H, Booth BA, Brickman TJ, Katt WC, Boesman-Finkelstein M, Finkelstein RA.

J Clin Microbiol. 1986 Aug;24(2):298-300.

21.

Vibrio cholerae hemagglutinin/protease nicks cholera enterotoxin.

Booth BA, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1984 Sep;45(3):558-60.

22.

Preparation of procoligenoids from Escherichia coli heat-labile enterotoxins.

Finkelstein RA, Sciortino CV, Rieke LC, Burks MF, Boesman-Finkelstein M.

Infect Immun. 1984 Aug;45(2):518-21.

23.

Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme.

Booth BA, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1983 Nov;42(2):639-44.

24.

Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited.

Finkelstein RA, Boesman-Finkelstein M, Holt P.

Proc Natl Acad Sci U S A. 1983 Feb;80(4):1092-5.

25.

Observations on the Texas Star-SR avirulent A-B+ mutant candidate cholera vaccine.

Finkelstein RA, Boesman-Finkelstein M.

Dev Biol Stand. 1983;53:89-92.

PMID:
6873480
26.

Sequential purification of lactoferrin, lysozyme and secretory immunoglobulin A from human milk.

Boesman-Finkelstein M, Finkelstein RA.

FEBS Lett. 1982 Jul 19;144(1):1-5. No abstract available.

27.
28.

The kinetics of rat liver citrate synthase in situ.

Matlib MA, Boesman-Finkelstein M, Srere PA.

Arch Biochem Biophys. 1978 Dec;191(2):426-30. No abstract available.

PMID:
33594
29.

Cholera and related diarrhoeas ('turista').

Finkelstein RA, Boesman-Finkelstein M.

Nature. 1978 Sep 21;275(5677):173-4. No abstract available.

PMID:
357986

Supplemental Content

Loading ...
Support Center